Insmed vs STERIS
Insmed (INSM), health care, and STERIS (STE), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Insmed is worth $26.7B on the stock market and STERIS $25B: Insmed is valued at 7% more. Insmed's operating margin in its latest fiscal year was -206% and STERIS's 18.6%. Over the past year Insmed's share price has moved -39.1% and STERIS's +1.91%.
Key facts
- Insmed market value
- $26.7B
- STERIS market value
- $25B
- STERIS P/E
- 30.5
- Insmed revenue
- $606.4MFY to 2025-12-31
- STERIS revenue
- $5.9BFY to 2026-03-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Insmed | STERIS |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2026-03-31 |
| Size | ||
| Market cap | $26.7Bhigher | $25Blower |
| Revenue | $606.4Mlower | $5.9Bhigher |
| Earnings | -$1.3Blower | $782.3Mhigher |
| Employees | 1,664lower | 17,937higher |
| Total assets | $2.3Blower | $10.7Bhigher |
| Valuation | ||
| P/E | — | 30.5 |
| P/S | 44.1higher | 4.2lower |
| P/B | 36.8 | — |
| Dividend yield | 0.00% | — |
| Profitability | ||
| Operating margin | -206%lower | 18.6%higher |
| Balance sheet | ||
| Net assets | $739Mlower | $7.2Bhigher |
| Total liabilities | $1.5Blower | $3.5Bhigher |
| Total debt | $546.8Mlower | $1.9Bhigher |
| Cash on hand | $510.4Mhigher | $439.6Mlower |
| Price change | ||
| Today | -0.83%higher | -1.46%lower |
| 1 year | -39.1%lower | +1.91%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Percentages are each holding's share of that investor's reported portfolio. Who owns INSM · Who owns STE
More on Insmed
Further comparisons
Insmed against its closest peers
STERIS against its closest peers
Learn
Questions and answers
Which is bigger, Insmed or STERIS?
By market value, Insmed is the larger: $26.7B against $25B for STERIS. By revenue in its latest fiscal year, STERIS is the larger: $5.9B against $606.4M for Insmed.
Which has the higher operating margin?
STERIS: 18.6%, against -206% for Insmed. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
STERIS: $1.9B, against $546.8M for Insmed. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Insmed and STERIS?
None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Insmed and 1 holds STERIS.
Cite this page
Funkfolio, “Insmed vs STERIS”, data as of 17 November 2026. https://funkfolio.com/compare/insm-vs-ste
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.